4DMedical Limited (ASX:4DX)
Australia
· Delayed Price · Currency is AUD 1.810
+0.060 (3.43%)
Sep 26, 2025, 4:10 PM AEST
4DMedical Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Revenue | 5.85 | 3.75 | 0.72 | 1.05 | 0.22 | Upgrade
|
| Revenue Growth (YoY) | 55.91% | 422.45% | -31.84% | 385.90% | -82.39% | Upgrade
|
| Cost of Revenue | 0.46 | 0.24 | 0.03 | 0.77 | 0.09 | Upgrade
|
| Gross Profit | 5.39 | 3.52 | 0.68 | 0.28 | 0.13 | Upgrade
|
| Selling, General & Admin | 32.1 | 27.83 | 23.74 | 19.21 | 11.43 | Upgrade
|
| Other Operating Expenses | 16.12 | 17.53 | 18.95 | 16.32 | 12.26 | Upgrade
|
| Operating Expenses | 53.55 | 49.42 | 45.25 | 37.03 | 24.46 | Upgrade
|
| Operating Income | -48.16 | -45.91 | -44.57 | -36.75 | -24.34 | Upgrade
|
| Interest Expense | -0.26 | -0.26 | -0.29 | -0.18 | -2.69 | Upgrade
|
| Interest & Investment Income | 0.34 | 1.24 | 0.61 | 0.09 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.29 | 0.35 | -0.03 | -0.03 | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.63 | 10.97 | 13.15 | 12.32 | 5.55 | Upgrade
|
| EBT Excluding Unusual Items | -30.16 | -33.61 | -31.14 | -24.55 | -21.41 | Upgrade
|
| Merger & Restructuring Charges | - | -2.32 | - | - | - | Upgrade
|
| Pretax Income | -30.16 | -35.93 | -31.14 | -24.55 | -21.41 | Upgrade
|
| Income Tax Expense | -0.09 | 0.05 | 0.32 | 0.04 | 0.02 | Upgrade
|
| Net Income | -30.07 | -35.98 | -31.46 | -24.59 | -21.42 | Upgrade
|
| Net Income to Common | -30.07 | -35.98 | -31.46 | -24.59 | -21.42 | Upgrade
|
| Shares Outstanding (Basic) | 466 | 370 | 300 | 295 | 261 | Upgrade
|
| Shares Outstanding (Diluted) | 466 | 370 | 300 | 318 | 283 | Upgrade
|
| Shares Change (YoY) | 25.66% | 23.49% | -5.59% | 12.14% | 92.94% | Upgrade
|
| EPS (Basic) | -0.06 | -0.10 | -0.10 | -0.08 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.11 | -0.10 | -0.08 | -0.08 | Upgrade
|
| Free Cash Flow | -34.56 | -31.02 | -23.07 | -27.92 | -15.1 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.08 | -0.08 | -0.09 | -0.05 | Upgrade
|
| Gross Margin | 92.07% | 93.69% | 95.25% | 26.62% | 57.67% | Upgrade
|
| Operating Margin | -822.76% | -1222.75% | -6202.49% | -3485.78% | -11217.15% | Upgrade
|
| Profit Margin | -513.72% | -958.34% | -4378.05% | -2332.63% | -9872.21% | Upgrade
|
| Free Cash Flow Margin | -590.45% | -826.34% | -3211.05% | -2647.86% | -6957.55% | Upgrade
|
| EBITDA | -45.82 | -44.75 | -43.83 | -36.34 | -24.15 | Upgrade
|
| D&A For EBITDA | 2.34 | 1.16 | 0.74 | 0.41 | 0.18 | Upgrade
|
| EBIT | -48.16 | -45.91 | -44.57 | -36.75 | -24.34 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.